DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. (XRAY) Financial Performance & Income Statement Overview
Review DENTSPLY SIRONA Inc. (XRAY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
DENTSPLY SIRONA Inc. (XRAY) Income Statement & Financial Overview
Review DENTSPLY SIRONA Inc. XRAY income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $879.00M | $905.00M | $951.00M | $984.00M |
| Cost of Revenue | $413.00M | $459.00M | $456.00M | $472.00M |
| Gross Profit | $466.00M | $446.00M | $495.00M | $512.00M |
| Gross Profit Ratio | $0.53 | $0.49 | $0.52 | $0.52 |
| R&D Expenses | $36.00M | $42.00M | $40.00M | $41.00M |
| SG&A Expenses | $360.00M | $395.00M | $391.00M | $401.00M |
| Operating Expenses | $403.00M | $955.00M | $957.00M | $461.00M |
| Total Costs & Expenses | $816.00M | $1.41B | $1.41B | $934.00M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $19.00M | $16.00M | $18.00M | $17.00M |
| Depreciation & Amortization | $79.00M | $88.00M | $89.00M | $86.00M |
| EBITDA | $142.00M | -$419.00M | -$371.00M | $157.00M |
| EBITDA Ratio | $0.16 | -$0.46 | -$0.39 | $0.16 |
| Operating Income | $63.00M | -$509.00M | -$462.00M | $50.00M |
| Operating Income Ratio | $0.07 | -$0.56 | -$0.49 | $0.05 |
| Other Income/Expenses (Net) | -$19.00M | -$14.00M | -$16.00M | -$16.00M |
| Income Before Tax | $44.00M | -$523.00M | -$478.00M | $34.00M |
| Income Before Tax Ratio | $0.05 | -$0.58 | -$0.50 | $0.03 |
| Income Tax Expense | $25.00M | -$95.00M | $17.00M | $38.00M |
| Net Income | $20.00M | -$430.00M | -$494.00M | -$4.00M |
| Net Income Ratio | $0.02 | -$0.48 | -$0.52 | -$0.004 |
| EPS | $0.10 | -$2.16 | -$2.46 | -$0.02 |
| Diluted EPS | $0.10 | -$2.16 | -$2.46 | -$0.02 |
| Weighted Avg Shares Outstanding | $199.10M | $203.20M | $201.00M | $205.60M |
| Weighted Avg Shares Outstanding (Diluted) | $199.80M | $203.20M | $201.00M | $205.60M |
Over the past four quarters, DENTSPLY SIRONA Inc. demonstrated steady revenue growth, increasing from $984.00M in Q2 2024 to $879.00M in Q1 2025. Operating income reached $63.00M in Q1 2025, maintaining a consistent 7% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $142.00M, reflecting operational efficiency. Net income rose to $20.00M, with EPS at $0.10. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan